Researchers have provided the molecular explanation for why some osteoporosis drugs offer protection against COVID-19.

Patients with osteoporosis who took bisphosphonates, especially risedronate, were at a higher risk of developing acute angle ...

Bisphosphonates are the mainstay of osteoporosis therapy. Extensive clinical evaluation supports their utility in stemming progression of the disease and in reducing fracture risk. In the course ...

Researchers have provided the molecular explanation for why some osteoporosis drugs offer protection against Covid-19. Drugs ...

"Among dialysis patients with osteoporosis, denosumab may be more effective than oral bisphosphonates in reducing fracture ...

For dialysis-dependent patients treated for osteoporosis, denosumab is associated with a greater preventive effect on fractures but an increased risk for major adverse cardiovascular events (MACE) ...

USPSTF said with "moderate certainty" that screening for osteoporosis to prevent osteoporotic fractures has a moderate net ...

Researchers identified how bisphosphonates, used to treat osteoporosis, might reduce Covid-19 risks. Drugs such as ...

Researchers have provided the molecular explanation for why some osteoporosis drugs offer protection against Covid-19.